Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial

Telomere dysfunction and chromothripsis

(2016) Aurélie Ernst et al.   INTERNATIONAL JOURNAL OF CANCER

Erratum: Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis

(2015) L Bassaganyas et al.   LEUKEMIA

Mutations driving CLL and their evolution in progression and relapse

(2015) Dan A. Landau et al.   NATURE

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

(2013) E. Chigrinova et al.   BLOOD

Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia

(2013) Dan A. Landau et al.   CELL

Clonal Evolution, Genomic Drivers, and Effects of Therapy in Chronic Lymphocytic Leukemia

(2013) P. Ouillette et al.   CLINICAL CANCER RESEARCH

Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome

(2013) Giulia Fabbri et al.   JOURNAL OF EXPERIMENTAL MEDICINE

High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations

(2012) J. Edelmann et al.   BLOOD

Minimal Residual Disease Quantification Is an Independent Predictor of Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia: A Multivariate Analysis From the Randomized GCLLSG CLL8 Trial

(2012) Sebastian Böttcher et al.   JOURNAL OF CLINICAL ONCOLOGY

Clonal evolution in cancer

(2012) Mel Greaves et al.   NATURE

TP53Mutation and Survival in Chronic Lymphocytic Leukemia

(2010) Thorsten Zenz et al.   JOURNAL OF CLINICAL ONCOLOGY

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

(2010) M Hallek et al.   LANCET